The document provides information about investigating and treating myocardial infarction (MI). It discusses investigations like ECG changes, cardiac enzyme levels including troponin and CK-MB, echocardiography, and other tests. General management of MI includes bed rest, aspirin, morphine, oxygen, beta blockers, thrombolytics or angioplasty. Complications include arrhythmias and heart damage. Follow up involves medication, lifestyle changes, and cardiac rehabilitation.
The document provides information about investigating and treating myocardial infarction (MI). It discusses investigations like ECG changes, cardiac enzyme levels including troponin and CK-MB, echocardiography, and other tests. General management of MI includes bed rest, aspirin, morphine, oxygen, beta blockers, thrombolytics or angioplasty. Complications include arrhythmias and heart damage. Follow up involves medication, lifestyle changes, and cardiac rehabilitation.
The document provides information about investigating and treating myocardial infarction (MI). It discusses investigations like ECG changes, cardiac enzyme levels including troponin and CK-MB, echocardiography, and other tests. General management of MI includes bed rest, aspirin, morphine, oxygen, beta blockers, thrombolytics or angioplasty. Complications include arrhythmias and heart damage. Follow up involves medication, lifestyle changes, and cardiac rehabilitation.
Lecture No: Z-16 Topic:Myocardial Infarction Investigation & Treatment Ms. Anum Hanif Lecturer Faculty of Pharmacy Hajvery University (HU) Learning Outcomes Students will learn in this lecture about: •How to investigate Myocardial Infarction •General Measures •Treatment •Complications •Follow up Investigations: • According to the WHO criteria myocardial infarction can be diagnosed, if two of the following factors are present: • A history of ischemic type chest pain. • ECG changes of myocardial infarction. • Initially a rise and then fall of cardiac Enzymes. ECG: • The classical evolution of ECG changes is myocardial infarction are: • Peaks (hyper-acute) T waves →ST segment elevation→ formation of Q waves →T wave inversion. • These changes may occur over a few hour to several days. •Occasionally initial ECG is normal and diagnostic changes appear a few hour later, therefore serial ECGs increase the yield of diagnosis. •Interpretation of EGC become difficult when there is a bundle branch block or previous myocardial infarction. Cardiac enzyme: • Myocardial infarction leads to detectable rise in the plasma concentration of the enzymes normally confined within cardiac cells. •The enzymes most widely used in the detection of myocardial infarction are following: Cardiac specific troponins Troponin T and troponin I: • These enzymes are highly specific to cardiac injury and can detect small infarctions that are below the detection limit for CK-MB. •Troponin T and I rise early (within 2-4 hours) and remained elevated. • Troponin I, 7-10 days. • Troponin T, 10-14 days. • Therefore these enzymes are specially helpful if a patient comes 2-3 days after infarction because CK-MB returns to normal till that time while these enzymes remain elevated. •Although LDH is also elevated for 10 days but it is non specific and is also elevated in other conditions. • Troponin T kits are available in the market and this test can be performed at the bed side . •This is now most widely used test for cardiac marker. Creatine Kinase (CK) • It rises within 4-8 hours, peaks at 24 hour and generally return to normal by 2-3 days. • Creatine kinase has three iso-enzymes • CK-MB----present in heart. • CK-MM----present in skeletal muscles and heart. • CK-BB-----present in brain. Echocardioagraphy: •Echocardioagraphy provides convenient bedside assessment of left ventricular global and regional function. •This may be helpful in diagnosis and management of infarction. Other Serum Markers: • Aspartate aminotransferase(AST) • Lactate dehydrogenase(LDH) • Blood CP/ ERS • X-ray chest • Echocardiography • Radionuclide scan Management: • All patients with suspected myocardial infarction should be confines to strict bed rest and admitted in hospital preferably in ICU. General Measures: 1. An I/V cannula is inserted for emergency medication. 2. Morphine 4-8 mg I/V + cyclizine 50 mg I/V to relieve pain. 3. Oral aspirin (300 mg) one tablet chewable. 4. Nitroglycerin (Angised) sublingually if blood pressure is stable. 5. Oxygen if saturation is low. 6. Intravenous beta blockers (Lopressor 5 mg ) if tachycardia. 7. Thrombolytic streptokinase 1.5 million units over 1 hour. 8.Acute angioplasty (primary percutaneous intervention PCI) if thrombolytic therapy is contraindicated. 9. Isosorbide dinitrate or nitroglycerin for 24-48 hours to relieve persistent pain if blood pressure is stable. 10. For anxiety use medicine such as Alprazolam (Xanax 0.5mg). 11. Bed rest for first 24-48 hours with bedside commode facility. Smoking should not be allowed. Complications: • Arrythmias. • Murmur of venticular septal defect. • Mitral regurgitation. • Pericardial rub. Follow up treatment and secondary prevention: • Initially Ambulation limited to home. • No heavy lifting weights. • Stop smoking. • Reduce weight. • Control blood pressure. • Gradually increased activity, cardiac rehabilitation and exercise training after 4-8 weeks. • Sub maximal ETT or persantin thallium scan before discharge (after 3-5 days of uncomplicated MI). • Returning to work after 6-8 weeks. • Strict sugar control in diabetics. • LDL cholesterol should be lowered below 100mg/dl with lipid lowering drugs such as statins (simvastatins, atrovastatin). • Aspirin continue indefinitely. Beta blocker has been shown to reduce the incidence of death in six months following an acute myocardial infarction. • One of the beta blockers e.g. Metoprolol 50mg twice daily. Atenolol 100 mg once daily • ACE inhibitors: prevent progressive left ventricular dilation and dysfunction. • Air travel: air travel should be avoided for 3 weeks after MI even the patient is asymptomatic. Summary Students have learnt about the: •How to investigate Myocardial Infarction •General Measures •Treatment •Complications •Follow up 1. Students you can ask any question regarding this lecture. 2. Google Classroom discussion board.
(Cancer Drug Discovery and Development) Ulrike S. Stein PhD, Wolfgang Walther PhD, Peter M. Schlag MD, PhD (Auth.), Peter M. Schlag MD, Ulrike Stein PhD, Alexander M. M. Eggermont MD, PhD (Eds.)-Regio